| BCBS Federal Medical & Drug | 5.85.025 Endari (L-glutamine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.026 Haegarda (C1 esterase inhibitor human) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.030 Doptelet (avatrombopag) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.034 Cablivi (caplacizumab-yhdp) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.036 Adakveo (crizanlizumab-tmca) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.040 Orladeyo (berotralstat) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.041 Nascobal (cyanocobalamin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.042 Empaveli (pegcetacoplan) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.043 Tavneos (avacopan) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.85.045 Enjaymo (sutimlimab-jome) | 2026-03-06 |